BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32770778)

  • 1. Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study.
    Rahimi-Levene N; Chezar J; Yahalom V;
    Transfusion; 2020 Nov; 60(11):2684-2690. PubMed ID: 32770778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
    Smith HM; Shirey RS; Thoman SK; Jackson JB
    Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
    Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
    Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Anti-D titers in RhD-negative pregnant women on fetuses and newborns: A retrospective study.
    Tang TH; Guo CY; Li XY; Hu YX; Liu WK; Yu MX
    Pediatr Neonatol; 2024 May; 65(3):288-292. PubMed ID: 37957047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
    Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
    Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
    Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
    AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
    Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
    Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan.
    Moinuddin I; Fletcher C; Millward P
    J Blood Med; 2019; 10():283-289. PubMed ID: 31692490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
    Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic disease of fetus and newborn due to maternal red blood cell alloantibodies in the Malay population.
    Hassan MN; Mohd Noor NH; Johan Noor SR; Sukri SA; Mustafa R; Luc Aster HV
    Asian J Transfus Sci; 2014 Jul; 8(2):113-7. PubMed ID: 25161351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn.
    Singh B; Chaudhary R; Katharia R
    Transfus Apher Sci; 2021 Feb; 60(1):102958. PubMed ID: 33039278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital.
    Sánchez-Durán MÁ; Higueras MT; Halajdian-Madrid C; Avilés García M; Bernabeu-García A; Maiz N; Nogués N; Carreras E
    BMC Pregnancy Childbirth; 2019 Oct; 19(1):356. PubMed ID: 31615430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
    Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
    Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
    De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
    Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.